X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8) 8
humans (7) 7
pharmacology & pharmacy (7) 7
absorption (4) 4
administration, oral (3) 3
animals (3) 3
drug dosages (3) 3
metabolism (3) 3
permeability (3) 3
pharmaceutical preparations - metabolism (3) 3
respiratory system (3) 3
bioavailability (2) 2
biopharmaceutics - methods (2) 2
biotransformation (2) 2
cardiac & cardiovascular systems (2) 2
classification (2) 2
double-blind (2) 2
male (2) 2
medicine & public health (2) 2
metabolites (2) 2
middle aged (2) 2
pharmaceutical preparations - administration & dosage (2) 2
pharmacokinetics (2) 2
pharmacology (2) 2
pharmacology/toxicology (2) 2
pulmonary arterial-hypertension (2) 2
pulmonary hypertension (2) 2
pyrimidines - pharmacokinetics (2) 2
solubility (2) 2
soluble guanylate-cyclase (2) 2
1-phosphatidylinositol 3-kinase (1) 1
9553 (1) 1
acetylcholine-receptors (1) 1
adme (1) 1
administration, intravenous (1) 1
adult (1) 1
adults (1) 1
allosteric regulation (1) 1
amino-acids (1) 1
anti-inflammatory (1) 1
antiretroviral drugs (1) 1
antivirals (1) 1
apoptosis (1) 1
atropine derivatives - chemical synthesis (1) 1
atropine derivatives - chemistry (1) 1
atropine derivatives - pharmacology (1) 1
aufsatzsammlung (1) 1
azithromycin (1) 1
bacteria - metabolism (1) 1
bacterial degradation (1) 1
basic medicine (1) 1
bay 63-2521 (1) 1
bay 80-9646 (1) 1
bibliografi: särskilda personer (1) 1
bibliographie (1) 1
bile acids and salts - chemistry (1) 1
binding sites (1) 1
biological availability (1) 1
biopharmaceutics (1) 1
biopharmaceutics classification system (1) 1
biorelevant dissolution testing (1) 1
blood plasma (1) 1
bronchiectasis (1) 1
caco-2 cells (1) 1
calcium channel blockers - administration & dosage (1) 1
calcium channel blockers - pharmacology (1) 1
cancer research (1) 1
cardiology (1) 1
cell line, tumor (1) 1
chemistry, medicinal (1) 1
chemistry, pharmaceutical - methods (1) 1
cho cells (1) 1
ciprofloxacin (1) 1
class i phosphatidylinositol 3-kinases - antagonists & inhibitors (1) 1
class i phosphatidylinositol 3-kinases - pharmacokinetics (1) 1
class i phosphatidylinositol 3-kinases - therapeutic use (1) 1
clinical importance (1) 1
clinical pharmacokinetics (1) 1
clinical study (1) 1
clinical trials (1) 1
colon (1) 1
copanlisib (1) 1
cricetulus (1) 1
crystal-structure (1) 1
cyp3a4 (1) 1
cystic fibrosis (1) 1
cytochrome p450 (1) 1
databases, factual (1) 1
delayed-action preparations (1) 1
derivatives (1) 1
developability classification system (1) 1
development (1) 1
directories (1) 1
disposition (1) 1
dissolution (1) 1
dog (1) 1
dosage forms (1) 1
drug absorption (1) 1
drug database (1) 1
drug discovery (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Expert Opinion on Drug Metabolism & Toxicology, ISSN 1742-5255, 11/2019, Volume 15, Issue 11, pp. 975 - 984
Objectives: Riociguat is a soluble guanylate cyclase stimulator licensed for the treatment of pulmonary arterial hypertension (PAH), a potentially fatal... 
drug-drug interactions | in vitro-in vivo prediction (IVIVE) | liver/hepatic | Antivirals | pharmacokinetics | cytochrome p450 | enzyme inhibitors | Index Medicus
Journal Article
Journal Article
Pulmonary Pharmacology & Therapeutics, ISSN 1094-5539, 06/2019, Volume 56, pp. 86 - 93
There are only limited treatment options for patients with non-cystic fibrosis bronchiectasis (non-CF BE). Human neutrophil elastase (HNE) is a mediator of... 
Anti-inflammatory | Bronchiectasis | Neutrophil elastase | LONG-TERM | SPUTUM | INHALATION | PHASE-II | AZITHROMYCIN | RESPIRATORY SYSTEM | DOUBLE-BLIND | EXACERBATIONS | PHARMACOLOGY & PHARMACY | HEALTH | CIPROFLOXACIN | Clinical trials | Cystic fibrosis | Drug therapy
Journal Article
Pulmonary Circulation, ISSN 2045-8932, 5/2019, Volume 9, Issue 2, p. 204589401984864
Riociguat, a first-in-class soluble guanylate cyclase stimulator, is approved for the treatment of pulmonary arterial hypertension (PAH), a serious potential... 
MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | PULMONARY ARTERIAL-HYPERTENSION | SMOKING | PREVALENCE | HUMAN-IMMUNODEFICIENCY-VIRUS | soluble guanylate cyclase | IMPAIRMENT | PATHOGENESIS | THERAPY | HIV | RESPIRATORY SYSTEM | drug exposure | INFECTION | pulmonary arterial hypertension | Antiretroviral drugs | Drug dosages | Human immunodeficiency virus--HIV
Journal Article
Pulmonary circulation, ISSN 2045-8932, 04/2019, p. 2045894019848644
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 9/2017, Volume 80, Issue 3, pp. 535 - 544
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 08/2014, Volume 57, Issue 15, pp. 6739 - 6750
Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 01/2017, Volume 96, pp. 598 - 609
Journal Article
2003, Ergänzungsbände zum Reallexikon der germanischen Altertumskunde, ISBN 3110177781, Volume Bd. 37, xv, 1024
Book
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.